News

FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Axios2h
FDA plans to phase out animal testing requirements
Zoom in: FDA said its roadmap envisions using computer modeling and AI to predict a drug's behavior and possible side effects ...
Public Broadcasting Service (PBS)2h
FDA reverses course on telework after staff reductions threaten basic operations
A spokeswoman for Health Secretary Robert F. Kennedy Jr. said the administration is returning to “pre-COVID telework ...
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
RFK Jr. Says We'll Soon Know What's Fueling The Autism Epidemic, And His Prediction Is Absolutely Wild
Health Secretary Robert F. Kennedy Jr. declared Thursday that “by September we will know what has caused the autism epidemic, ...
Explore more
Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy
By Kamal Choudhury (Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and ...
National Law Review3h
A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA
The obvious result of the legal shootout between the U.S. Food & Drug Administration (FDA) and clinical laboratory trade associations, the American Clinical Laboratory Association and the Association ...
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
FDA staff cuts are already impacting regulatory work, Biotech leaders warn
Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.
STAT8h
Crucial FDA drug reviews expected to be slowed by job cuts
A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.